Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin-Reference-Cited by-同舟云学术

Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin

Published:2022 Issue:17 Volume:12 Page:7203-7215
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Reissig Falco,Zarschler Kristof,Novy Zbynek,Petrik Milos,Bendova Katerina,Kurfurstova Daniela,Bouchal Jan,Ludik Marie-Charlotte,Brandt Florian,Kopka Klaus,Khoylou Marta,Pietzsch Hans-Jürgen,Hajduch Marian,Mamat Constantin

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders;Nuclear Medicine and Biology;2024-11

2. Scalability study on [133La]LaCl3 production with a focus on potential clinical applications;EJNMMI Radiopharmacy and Chemistry;2024-08-15

3. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy;Pharmaceuticals;2024-08-05

4. Effect of Linker Entities on Pharmacokinetics of ¹¹¹In-Labeled Prostate-Specific Membrane Antigen-Targeting Ligands with an Albumin Binder;ACS Pharmacology & Translational Science;2024-07-09

5. Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics;Analytical Sciences;2024-04-02